Mr. Robert Abenante reports

ABATTIS COMPLETES INVESTMENT IN CANNANUMUS BLOCKCHAIN AND ANNOUNCES CANNANUMUS'S ACHIEVEMENT OF A SIGNIFICANT MILESTONE

Abattis Bioceuticals Corp. has completed its acquisition of a 49-per-cent stake in CannaNUMUS Blockchain Inc., pursuant to the investment agreement dated Jan. 31, 2018, between the company and CannaNUMUS.

The company is also pleased to announce that CannaNUMUS has achieved the first milestone under the investment agreement by entering into an agreement with Active Health Products Ltd. "We are excited to see such immediate progress on our investment in CannaNUMUS," stated Rob Abenante, president and chief executive officer of Abattis.

"We believe this is just the beginning of many more lucrative agreements and synergies for CannaNUMUS with licensed producers and also licensed dealers," added Mr. Abenante.

Abattis believes that its investment in CannaNUMUS will appreciate significantly in value as CannaNUMUS gets closer to an ICO and signs agreements with licensed producers and late-stage LP applicants.

Active Health, located in Duncan, B.C., is the second cannabis cultivation project for its founder and CEO, Jim Money. Mr. Money recently developed and sold Broken Coast Cannabis Inc., also located on Vancouver Island, for $230-million to Aphria Inc. Broken Coast is now successfully operating as a licensed producer.

Pursuant to Active Health's agreement with CannaNUMUS, CannaNUMUS will invest into Active Health and, in exchange, Active Health will participate as one of CannaNUMUS's blockchain portfolio companies. More specifically, Active Health will use a fixed percentage of its quarterly revenues to buy CannaNUMUS tokens on the open market and subsequently burn them. The effect of the buy and burn will be similar to that when a company repurchases its own stock, and will function as method of providing liquidity to the market for CannaNUMUS tokens. Token burning will also act as a low-friction method of returning value to token holders.

CannaNUMUS's innovative approach is expected to leverage blockchain technology in a way that brings market participants closer to the companies that they wish to support. Costly and laborious fund-administration procedures that are typical of many investment funds will replaced by a new, transparent approach to funding. When paired with well-managed companies like Active Health, there will be significant potential for changing the way that investors are involved in markets.

"With our model, you take well-managed companies, pair them with the investment oversight in CannaNUMUS, and support those relationships with transparent and secure technology," stated Simran Gill, CEO of CannaNUMUS. "At the end of the day, there's more left on the table for investors," added Mr. Gill.

About Abattis Bioceuticals Corp.

Abattis is a life sciences and biotechnology company which aggregates, integrates and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada. The company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. The company is also seeking to acquire exclusive intellectual property rights to agricultural technologies to be employed in extraction and processing of botanical ingredients and compounds.

We seek Safe Harbor.